Hubei Jianxiang Bioscience: difference between revisions
Diff·revision 20 → 21·04:55, 16 Jul 2025
Difference between revision 20 and revision 21 of Hubei Jianxiang Bioscience. 12 lines changed; the page grew by 696 bytes.
| Revision 20 — 20:33, 8 Jul 2025 BlankVialBo (talk) rv — see talk 6,282 bytes +318 | Revision 21 — 04:55, 16 Jul 2025 DMF_Dermot (talk) rv promotional edit 6,978 bytes +696 | ||
|---|---|---|---|
| 47 | | Injectable oils and raw materials | Bulk | Certificate, limited detail | | 47 | | Injectable oils and raw materials | Bulk | Certificate, limited detail | |
| 48 | 48 | ||
| + | 49 | The catalogue is close to the sector standard. Documentation on the incretin lines is better than on the bulk lines, the gradient described on most of these articles.{{r|reports}} | |
| + | 50 | ||
| + | 51 | == Independent testing record == | |
| + | 52 | Submitted reports on HJ material to July 2026 are concentrated on the incretin analogues, with reported [[Area percent purity|area percent]] figures clustering in the high nineties and, where a water figure accompanied them, purchaser-computed [[Peptide content|peptide content]] in the low-to-mid eighties by mass.{{r|reports,usp1503}} | |
| + | 53 | ||
| 49 | == References == | 54 | == References == |
| 50 | {{reflist}} | 55 | {{reflist}} |
| ⋮ | ⋮ | ||
| 55 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | 60 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> |
| 56 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 61 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 62 | ||
| + | 63 | == See also == | |
| + | 64 | * [[Certificate of analysis]] | |
| + | 65 | * [[Third-party testing]] | |
| + | 66 | * [[Area percent purity]] | |
| + | 67 | * [[Peptide content]] | |
| + | 68 | * [[Research use only]] | |
| 57 | 69 | ||
| 58 | {{DEFAULTSORT:Hubei Jianxiang Bioscience}} | 70 | {{DEFAULTSORT:Hubei Jianxiang Bioscience}} |